Close



Apr 3, 2024 05:43AM
Apr 2, 2024 06:10PM
Mar 6, 2024 07:01AM
Mar 6, 2024 07:00AM
Feb 7, 2024 04:02PM
Feb 5, 2024 08:01AM
Feb 5, 2024 08:00AM Vanda Pharmaceuticals Announces FDA Update for supplemental NDA for HETLIOZ® in the Treatment of Insomnia
Jan 31, 2024 09:01AM
Jan 31, 2024 09:00AM
Jan 30, 2024 12:35PM
Jan 30, 2024 05:45AM
Jan 29, 2024 07:00PM
Jan 25, 2024 10:05PM
Jan 25, 2024 01:07PM Vanda Pharmaceuticals announces the publication of an article on "The Efficacy of Tradipitant in Patients with Diabetic and Idiopathic Gastroparesis in Phase III Randomized Placebo-Controlled Cli
Jan 23, 2024 09:16AM
Jan 23, 2024 09:15AM
Jan 19, 2024 03:57PM
Jan 19, 2024 03:56PM
Jan 17, 2024 03:47PM
Jan 17, 2024 03:46PM
Jan 12, 2024 12:26PM Vanda Pharmaceuticals (VNDA) Comments on FDA's Recently Announced Guidance on Communication with Health Care Professionals Regarding FDA-Approved Drugs
Jan 12, 2024 12:21PM
Dec 7, 2023 07:00AM
Dec 7, 2023 07:00AM
Dec 4, 2023 06:00PM
Nov 8, 2023 04:01PM
Jul 27, 2023 04:01PM
Jun 2, 2023 05:59AM Vanda Pharmaceuticals (VNDA) Announces Orphan Drug Designation Granted for VCA-894A
Jun 1, 2023 09:31PM
May 25, 2023 07:00AM
May 25, 2023 07:00AM
May 3, 2023 04:01PM
May 2, 2023 12:54PM
May 2, 2023 12:46PM
Mar 28, 2023 01:26PM Vanda Prevails in Jet Lag Litigation Against the FDA
Feb 8, 2023 04:01PM
Dec 19, 2022 07:01AM
Dec 19, 2022 07:00AM
Dec 2, 2022 07:03AM
Dec 2, 2022 07:00AM
Nov 2, 2022 04:01PM
Oct 21, 2022 02:01PM Vanda Pharmaceuticals (VNDA) Announces Orphan Drug Designation Granted for VPO-227, a Novel Candidate for the Treatment of Cholera
Oct 21, 2022 02:00PM
Sep 7, 2022 06:38PM
Aug 3, 2022 04:01PM
May 5, 2022 04:10PM
Feb 25, 2022 08:35AM
Feb 4, 2022 07:01AM
Feb 4, 2022 07:00AM Vanda Pharmaceuticals Reports Results from the Phase III Study of Tradipitant in Gastroparesis
Jan 14, 2022 08:36AM

251,374 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All